Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Niklas Prager Appointed New CEO of SmartCella
SmartCella Holding AB has today announced that Niklas Prager has been appointed as the new […]
Voyager Therapeutics Announces Appointment of George Scangos, Ph.D., to Board of Directors
Voyager Therapeutics, a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, […]
Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as Chief Executive Officer
Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel […]
Nutcracker Therapeutics Appoints Cynthia Collins, Biopharma Veteran and Former Editas Medicine CEO, to Board of Directors
Nutcracker Therapeutics, a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology […]
CardiaCare Names Ken Nelson Chairman of its Board of Directors
CardiaCare, a clinical-stage digital therapeutic company developing the world’s first non-invasive, neuromodulation wearable for atrial […]
CANbridge Pharmaceuticals Appoints Jason West Vice President, Head of Gene Therapy Research
CANbridge Pharmaceuticals, a global biopharmaceutical company, with a foundation in China, committed to the research, […]
Gameto Expands Executive Team with the Addition of Teri Loxam as Chief Financial Officer
Gameto, a female-led biotech company developing therapies to improve the female reproductive journey, today announced […]
RenovoRx Appoints Former Chief Medical Officer of Schering-Plough, Robert J. Spiegel, MD, FACP, to Board of Directors
RenovoRx, a biopharmaceutical company focused on targeted drug-delivery with an initial application in locally advanced […]
Xencor Appoints Nancy Valente, M.D., as Chief Development Officer
Xencor, a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer […]
RQM+ Appoints Steven Pilewski as Lab Services Chief Operating Officer
RQM+, the world’s leading MedTech service provider, has announced the appointment of Steven Pilewski as […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more